Skip to content

Pulpotomy With Various MTA Materials and Ferric Sulphate

Clinical and Radiographic Comparison of RetroMTA, OrthoMTA And Ferric Sulfate for Pulpotomy in Primary Molars

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03718676
Enrollment
32
Registered
2018-10-24
Start date
2017-06-02
Completion date
2018-12-30
Last updated
2019-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulpotomy

Keywords

pulpotomy

Brief summary

The aim of this study was to determine clinical and radiographic efficacy of the newly developed OrthoMTA and RetroMTA , compared frequently used ferric sulfate for pulpotomy in primary second molars.

Detailed description

A total of 96 second primary second molars from 32 children ,who met inclusion criteria and were 5-9 years old were selected for the study. Teeth were randomly divided into three groups according to the planned treatment: O-MTA (n=32 teeth), R-MTA (n=32 teeth) and FS (n=32 teeth). Clinical and radiographical follow-up examinations were conducted at 3, 6 and 9 months postoperatively. The data were evaluated with Chi-square test, Cochran Q test, Post-Huc Dunn test and Kaplan-Meier analysis.

Interventions

Teeth were pulpotomized with ferric sulphate in this group.

PROCEDUREOrtho-MTA

Teeth were pulpotomized with Ortho-MTA in this group.

PROCEDURERetro-MTA

Teeth were pulpotomized with Retro-MTA in this group.

Sponsors

Aydin Adnan Menderes University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
5 Years to 9 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients have at least three deep carious primary second molars * Teeth with no spontaneous pain * Patient who are willing to participate * Cooperative children

Exclusion criteria

* Patients who are not willing to participate * History of systemic disease * Pathological mobility * Presence of internal or external root resorption * Presence of apical radiolucency

Design outcomes

Primary

MeasureTime frameDescription
Clinical success rateChange of clinical success from Baseline at 18 monthsClinical success

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026